Attending Digital Health Festival? Click here.
The voice of business news for healthcare
Hon Anne Ruston adresses APP 2026 Conference

What APP 2026 taught us about where primary care in Australia is heading

×

Share this article

read time 4 min

Key takeaways

  • Insights from APP 2026 point to pharmacy becoming the frontline access point for primary care
  • Full scope is shifting from policy discussion to commercial reality
  • Operational capability, not clinical skill, is the main barrier to scale
  • Patient expectations are moving toward instant, convenience-led care

This was not just a pharmacy conference

The Veri Health team was on the ground at the Australian Pharmacy Professional (APP) Conference on the Gold Coast from 20–22 March 2026.

Across three days of sessions, conversations, and time spent on the exhibition floor, one thing became clear very quickly.

This was not a conversation about pharmacy alone. It was a signal of where primary care in Australia is heading.

Across multiple sessions and discussions, a consistent theme emerged. The system is under pressure, and the current model is not keeping up with demand.

Pharmacy is changing.

As Tom Murray, President of the Irish Pharmacy Union, explained, “Pharmacists are the most accessible healthcare professionals in every community.”

That accessibility is no longer just an advantage. It is becoming a defining feature of how care will be delivered.

Dispensing is no longer the endpoint

One of the clearest patterns the Veri Health team observed across sessions was a reframing of pharmacy’s core role.

For years, pharmacy has been described as an untapped part of the healthcare system. At APP 2026, it became clear that it is now being activated.

What stood out was not just the expansion of services such as prescribing, vaccinations and diagnostics. It was how those services were positioned.

Dispensing is no longer the end point. It is the entry point.

“Dispensing is the first step in clinical care,” Murray said.

This shift changes how pharmacies position themselves, how patients engage with them, and how the broader system can utilise them.

In Ireland, expanded pharmacy services are already estimated to remove around one million GP visits annually.

In a system like Australia’s, facing workforce shortages and rising demand, the implications are significant.

Full scope has become a business decision

Another consistent insight from APP, reinforced across multiple operators the Veri Health team spoke with, is that full scope is no longer theoretical.

It is operational. And it is commercial. Not adopting is no longer a neutral position.

“If you haven’t started yet, you are already losing ground.”

The data shared at the conference reinforces this.

Pharmacies implementing clinical services are not only improving access. They are:

  • attracting new patients
  • increasing repeat visits
  • strengthening long-term patient value

This is not simply a clinical evolution. It is a shift in how healthcare businesses create value.

“The consult is not the product. The relationship is.”

That insight extends beyond pharmacy and speaks to how all healthcare providers will need to think about patient engagement moving forward.

The real constraint is operational

A key takeaway from the sessions attended by the Veri Health team is that capability is not the limiting factor. Execution is.

Pharmacists already have the clinical knowledge to deliver many of these services. The challenge lies in how businesses are structured to support them.

As pharmacy owner Chelsea Felkai explained, “Resource allocation is fundamental to getting things done.”

This includes:

  • redesigning workflows to support consultations
  • using automation and AI to reduce manual tasks
  • structuring teams around strengths
  • creating capacity for patient-facing care

The pharmacies succeeding in this space are not simply adding services. They are redesigning how their businesses operate.

The mindset shift many are still resisting

One of the more confronting themes observed across APP is not operational, but cultural.

For decades, pharmacists have delivered clinical advice informally, often without charging. That model is no longer sustainable.

“One of the hardest lessons was learning to say: I value myself as a professional,” Murray said.

What stood out from discussions at the conference is that patients are not resisting this change.

They are willing to pay for:

  • faster access
  • convenience
  • trusted clinical advice

The resistance is often internal.

This may be one of the most significant barriers to scaling new models of care.

This shift will not stop at pharmacy

Stepping back, the biggest insight from APP is not about pharmacy alone. It is about direction.

What the Veri Health team observed across the three days is the early formation of a more accessible, consumer-driven, distributed and technology-enabled primary care system.

Pharmacy is leading this shift, but it will influence every part of the sector.

For GPs, allied health providers and healthcare entrepreneurs, the competitive landscape is already changing.

Patients are no longer comparing providers based on location alone. They are comparing experiences based on access, speed and convenience.

The takeaway for healthcare leaders

APP 2026 did not feel like a discussion about what might happen. It felt like a checkpoint on what is already underway.

Healthcare is moving closer to the patient. It is becoming faster, more accessible and increasingly shaped by experience as well as clinical care.

Pharmacy is simply the first to operationalise that shift at scale.

The question for the rest of the sector is not whether this model will expand.

It is whether your business is built to compete in it.

Part of the APP 2026 series

This article is part of Veri Health’s on-the-ground coverage of APP 2026, where our team spent three days analysing the shifts shaping primary care, business models and the future of healthcare delivery in Australia.

In our next article, we examine the commercial model behind full scope, and how pharmacies are building value beyond the consult.

Full scope is not a clinical shift, it is a business model transformation

In the last article, we examine why many pharmacies will struggle to implement full scope in practice, and what the top-performing operators are doing differently.

Why most pharmacies will struggle with full scope, and what the top performers are doing differently

×

Share this article